Patients that receive a lung transplant are always treated with immunosuppressive drugs to inactivate their immune system. We now make the discovery that a “proinflammatory” cell population known as the eosinophil is critical for long-term survival of the lung graft. Here we explore the physiology of this cell population in lung transplantation with the hope of improving long-term survival by devising novel lung-specific forms of immunosuppression.
|Effective start/end date||2/1/19 → 1/31/23|
- National Institute of Allergy and Infectious Diseases: $539,375.00
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.